期刊文献+

Rosuvastatin inhibits the smooth muscle cell proliferation by targeting TNFα mediated Rho kinase pathway 被引量:3

Rosuvastatin inhibits the smooth muscle cell proliferation by targeting TNFα mediated Rho kinase pathway
下载PDF
导出
摘要 Objective To investigate whether Tumor Necrosis Factor-alpha (TNFα) is capable of activating Rho kinase pathway which leads to smooth muscle cell proliferation and the intervention function of Rosuvastatin, and clarify the mechanism and intervention manner of anti-atherosclerosis by Rosuvastatin. Methods Wistar neonate rat smooth muscle cells were cultured, and the activity of cell proliferation was determined by methyl thiazolyl tetrazolium (MTT). The expression of Rho kinase genes after the stimulation of TNFα was evaluated by RT-PCR. Western blot method was used to measure the protein expression of proliferating cell nuclear antigen (PCNA) after TNFα stimulation and Rosuvastatin intervention in smooth muscle cell. Results The TNFα stimulation significantly enhanced the expression of Rho kinase and increased the expression of PCNA protein in smooth muscle cells (P 〈 0.05). These effects were positively correlated with prolonged treatment whereas additional Rosuvastatin administration inhibited the above-mentioned effects (P 〈 0.05). Conclusions The activation of TNFα mediated Rho kinase signaling pathway can significantly promote smooth muscle cell proliferation, and Rosuvastatin can not only inhibit this pathway but also the induced proliferation.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2012年第2期180-184,共5页 老年心脏病学杂志(英文版)
关键词 Tumor necrosis factor-alpha Rho kinase Signaling transduction Vascular smooth muscle cell 血管平滑肌细胞 瑞舒伐他汀 细胞增殖 TNF Rho 激酶 介导 肿瘤坏死因子-α
  • 相关文献

参考文献3

二级参考文献36

  • 1张曼,曾定尹.法舒地尔对压力负荷心力衰竭大鼠的作用[J].中国医科大学学报,2004,33(6):484-486. 被引量:4
  • 2孙波 刘文利.右心导管测定大鼠肺动脉压的实验方法[J].中国医学科学院学报,1984,6:465-465.
  • 3Li M,Liu Y,Dutt P,et al.Inhibition of serotonin-induced mitogenesis,migration,and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.Am J Physiol Lung Cell Mol Physiol,2007,293:L463-L471.
  • 4Humbert M.Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension:pathophysiology.Eur Respir Rev,2010,19:59-63.
  • 5Morrell NW,Adnot S,Archer SL,et al.Cellular and molecular basis of pulmonary arterial hypertension.J Am Coll Cardiol,2009,54(1 Suppl):S20-S31.
  • 6Alegret M,Silvestre JS.Pleiotropic effects of statins and related pharmacological experimental approaches.Methods Find Exp Clin Pharmacol,2006,28:627-656.
  • 7Cordle A,Koenigsknecht-Talboo J,Wilkinson B,et al.Mechanisms of statin-mediated inhibition of small G-protein function.J Biol Chem,2005,280:34202-34209.
  • 8Carlino C,Tobias JD,Schneider RI,et al.Pulmonary hemodynamic response to acute combination and monotherapy with sildenafil and brain natriuretic peptide in rats with monocrotalineinduced pulmonary hypertension.Am J Med Sci,2010,339:55-59.
  • 9Sun X,Ku DD.Rosuvastatin provides pleiotropic protection against pulmonary hypertension,right ventricular hypertrophy,and coronary endothelial dysfunction in rats.Am J Physiol Heart Circ Physiol,2008,294:H801-H809.
  • 10DeMarco VG,Habibi J,Whaley-Connell AT,et al.Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.Am J Physiol Heart Circ Physiol,2009,297:H1128-H1139.

共引文献65

同被引文献8

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部